pre-IPO PHARMA

COMPANY OVERVIEW

Oncoceutics, Inc. is a clinical-stage drug discovery and development company with a novel class compounds that selectively target G protein-coupled receptors for oncology.


LOCATION

  • Philadelphia, PA, USA
  • New York, NY, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    http://oncoceutics.com/


    CAREER WEBSITE

    http://oncoceutics.com/careers/


    SOCIAL MEDIA


    INVESTORS

    calvert-holdings spring-mountain-capital


    PRESS RELEASES


    Nov 17, 2021

    Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine


    Jan 8, 2021

    Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program


    Jan 21, 2016

    Oncoceutics Begins Fifth Clinical Trial for ONC201


    Jan 21, 2016

    Oncoceutics Begins Fifth Clinical Trial for ONC201


    Oct 6, 2015

    Oncoceutics Closes Series A Financing for First-in-Class Cancer Drug


    For More Press Releases


    Google Analytics Alternative